PLATELET AGGREGATION INHIBITORS Flashcards
groups of drugs included:
- aspirin + other NSAIDs
- antagonists of ADP receptors
- GP (glycoprotein) IIb/IIIa receptor inhibitors
- phosphodiesterase 3 inhibitors
aspirin → mechanism of action:
- inhibit thromboxane A2 synthesis by inactivating COX-1 enzyme
- also anti-inflammatory & analgesic effects
aspirin → indications:
PREVENTION of MI, TIAs, ischemic stroke & other thrombotic events
aspirin → side effects:
- angioedema
- bronchospasm
- reye syndrome
- bleeding
- GI-tract symptoms
antagonists of ADP receptors:
- ticlopidine
- clopidogrel
- prasugrel
- ticagrelor
antagonists of ADP receptors → indications:
- prevention of TIAs & ischemic stroke
- clopidogrel → used after coronary stent placement
- prevention atherosclerotic events in MI
antagonists of ADP receptors → side effects:
- prolonged bleeding
- NO antidote!!!!
- granulocytosis, thrombotic thrombocytopenic purpura, aplastic anemia
GP (glycoprotein) IIb/IIIa receptor inhibitors:
- abciximab
- tirofiban
- eptifibatide
GP IIb/IIIa receptor inhibitors → pharmacokinetics:
given IV → along with heparin & aspirin
GP IIb/IIIa receptor inhibitors → indications:
- prevention of restenosis after coronary angioplasty
2. treatment of acute coronary syndromes
GP IIb/IIIa receptor inhibitors → side effects:
- may worsen ischemia because of vasodilation
- headache
- orthostatic hypotension
phosphodiesterase 3 inhibitors:
- dipyridamole
2. cilostazol
phosphodiesterase 3 inhibitors → mechanism of action:
- inhibitors of phosphodiesterase 3 → vasodilation
2. increase cAMP → resulting in decreased thromboxane A2 synthesis
phosphodiesterase 3 inhibitors → indications:
- dipyridamole → with aspirin to PREVENT ischemic stroke, adjunct to warfarin in valve replacement
- cilostazol → treat intermittent claudication
phosphodiesterase 3 inhibitors → side effects:
- headache
- GI-tract problems
- increase mortality in advanced heart failure (contraindicated)